Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Cordis Corp. Receives FDA Clearance For ADROIT Guiding Catheter - Quick Facts

RELATED NEWS
Trade JNJ now with 

Cordis Corporation, part of the Johnson & Johnson Family of Companies (JNJ: Quote) announced that it has received clearance from the Food and Drug Administration or FDA of its latest innovation in guiding catheters: the ADROIT 6F Guiding Catheter.

The ADROIT Catheter's innovative hybrid braid wire technology not only enables the production of a guide catheter with the largest lumen size on the U.S. market, it also facilitates better control and back up support. In addition, the new innovative design incorporating a flexible distal segment and soft longer tip allows atraumatic placement and stability, the company stated.

Cordis said that the ADROIT Guiding Catheter provides a wide range of shapes, including extra back-up shapes and radial specific shapes to support treatment needs of various coronary anatomies.

Click here to receive FREE breaking news email alerts for Johnson & Johnson and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After turning in a lackluster performance for much of the session, stocks managed to end Wednesday's trading mostly higher. The gains lifted the Dow and the S&P 500 to new record closing highs, while the Nasdaq reached its best levels since 2000. Half of Americans agree with the changes to immigration policy announced by President Barack Obama last week, according to a CNN/ORC poll, although a majority opposes using executive orders to implement those policies. While Mitt Romney has said he has no plans to run for president again, the results of a Quinnipiac University national poll released Wednesday show the former Massachusetts Governor leading a group of potential Republican presidential candidates.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.